Biofunctionalized electronic devices

Efficient functionalized patterning is achieved by using field effect transistors of external stimulation-responsive polymer layer in biosensors, solving the sensor's challenges in detection accuracy and flux screening, and improving the sensitivity and cost-effectiveness of detection.

CN118946310APending Publication Date: 2024-11-12NEW YORK UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380027873.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-18
Filing Date
2023-03-20
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Existing biosensors have insufficient functionalization capabilities in achieving high-throughput screening of biochemical reactions and improving detection accuracy, especially in the challenge of selectively attaching target molecules to the active region and controlling spatial density distribution, and lack of universal cross-platform method.

Method used

Using a field effect transistor (FET) containing an external stimulus-responsive polymer layer, the functional groups of the polymer layer are activated by local external stimuli such as heat or electromagnetic radiation, exposing chemical functional groups for capturing the attachment of molecules, and achieving by click chemical reactions High resolution functionalized patterning.

Benefits of technology

It realizes efficient and reproducible control of molecular attachment on the sensing platform, improves the selectivity and sensitivity of the sensor, is suitable for parallel detection of multiple analytes, reduces costs and improves the time resolution of the detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005043980600000131
    Figure BDA0005043980600000131
  • Figure BDA0005043980600000151
    Figure BDA0005043980600000151
  • Figure BDA0005043980600000171
    Figure BDA0005043980600000171
Patent Text Reader

Abstract

The present invention relates to a device comprising a functionalized biosensor for detecting the presence of an analyte, comprising: a field effect transistor (FET) coated with an external stimulus-responsive polymer layer wherein the external stimulus-responsive polymer layer is configured to be modified to expose a chemical functional group via a localized external stimulus, the chemical functional group is configured to attach to a capture molecule. The invention also relates to methods of making the biofunctionalized biosensor and methods of detecting the presence of an analyte using the functionalized biosensor.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims the benefit of U.S. Provisional Application No. 63 / 321,337, filed on March 18, 2022, the disclosure of which is incorporated herein by reference in its entirety. Background of the Invention

[0004] The development of new sensing paradigms supports many exciting discoveries in life sciences. One goal of emerging sensing technologies is to achieve high-throughput screening of biochemical reactions at a lower cost and to improve detection accuracy. Among various emerging technologies, Bergveld's pioneering work revealed a new direction for large-scale parallel detection of biochemical reactions using silicon field effect transistors (FETs), the cornerstone of modern integrated circuits. In fact, traditional bulk silicon transistors are now commercially used for biosensing. In addition, the evolution of transistor technology to the use of nanoscale channel materials will directly benefit biochemical FET sensors (bioFETs) at a fundamental level. Specifically, many studies have shown that the response of bioFET sensors to external charges is improved by increasing the surface to volume ratio of channel materials using nanowires, nanotubes, and nanobelt structures. These bioFETs can detect various biochemical reactions with concentrations below a few picomoles.

[0005] While significant progress has been made in the development of electronic and optical sensors, one of the major issues remains the ability to functionalize the electronically active regions such that target molecules / biomolecules can be (i) selectively attached to the desired active regions and (ii) the spatial density distribution can be controlled and is consistent across all sensors in a sensing platform in a reproducible manner. Furthermore, there is currently a lack of universal methods to achieve such functionalization across different sensing platforms, devices, and materials.

[0006] In a related vein, biosensing is typically performed in two modalities. The first is electrical, such as the Ion Torrent DNA sensing platform. The second is optical sensing, such as Illumina. There is significant interest in this area to reduce the cost of sensing platforms as well as to reduce detection and processing times. Summary of the invention

[0007] In one aspect, the present invention relates to a device comprising a functionalized biosensor for detecting the presence of an analyte, comprising: a field effect transistor (FET) coated with an external stimulus-responsive polymer layer, wherein the external stimulus-responsive polymer layer is configured to be locally modified via a local external stimulus to expose a chemical functional group in a desired sensing area, the chemical functional group being configured to attach to a capture molecule. In one embodiment, the thermal-responsive polymer comprises a first functional group and a second functional group, wherein the external stimulus removes the first functional group from the polymer so that the second activated functional group is exposed. In one embodiment, the first functional group comprises at least one of a tetrahydropyranyl carbamate, an amine N-oxide, a tetrahydropyranyl ether, a trityl ether, a tetrahydropyranyl carbonate, an S-tetrahydropyranyl carbonyl, a diethyl disulfide, a cyclopropenone, and a tert-butyl ester group, and wherein the second activated functional group comprises at least one of an amine, an alcohol, a phenol, or a thiol. In one embodiment, the second functional group is an amine. In one embodiment, the polymer is produced by reversible addition fragmentation (RAFT) polymerization, atom transfer radical polymerization (ATRP), or nitroxide-mediated free radical polymerization.

[0008] In one embodiment, the polymer is of formula A m -B n wherein m and n are independently positive integers; A is a monomer residue comprising a crosslinking functional group; B comprises a monomer residue having a protected functional group, the protected functional group being deprotected by an external stimulus; and A and B are each connected to the polymer backbone. In one embodiment, the polymer is of formula A m -B n -C o Representation; wherein m, n and o are independently positive integers; A is a monomer residue comprising a crosslinking functional group; B comprises a monomer residue having a protected functional group, and the protected functional group can be deprotected by an external stimulus; and C is a monomer residue comprising a solubilizing group; wherein A, B and C are each connected to the polymer backbone. In one embodiment, A comprises methyl cinnamate. In one embodiment, B comprises at least one of tetrahydropyranyl carbamate, amine N-oxide, tetrahydropyranyl ether, trityl ether, tetrahydropyranyl carbonate, S-tetrahydropyranyl carbonyl, diethyl disulfide, cyclopropenone, and tert-butyl ester groups. In one embodiment, C comprises an alkyl, alkoxy or aryl chain. In one embodiment, the polymer backbone comprises one or more polymers selected from the group consisting of poly(methacrylate), poly(acrylate), poly(ester), poly(styrene), poly(amide), poly(olefin), and combinations, copolymers, statistical copolymers, gradient copolymers or block copolymers thereof.

[0009] In one embodiment, the external stimulus is heat and the polymer is thermoresponsive. In one embodiment, the functional group is generated or activated upon local heating of the thermoresponsive polymer. In one embodiment, the local external stimulus comprises electromagnetic radiation. In one embodiment, the exposed functional group comprises a functional group selected from the group consisting of thiols, alcohols, carboxylic acids and derivatives thereof, amines, alkynes, aldehydes and ketones. In one embodiment, the exposed functional group is further converted into an alkyne, an azide, a cycloalkyne, a cyclopropenone group. In one embodiment, the exposed functional group is configured to attach the desired capture molecule using a click chemistry reaction, the click chemistry reaction being selected from the group consisting of thiol-ene, thiol-alkyne, copper-catalyzed alkyne-azide cycloaddition, strain-promoted alkyne-azide cycloaddition, sulfur-fluoride exchange and Diels-Alder reaction. In one embodiment, the exposed functional groups are configured to attach desired capture molecules via 1,3-cycloaddition of diazides and diynes to form poly(arylenetriazolylene). In one embodiment, the exposed functional groups are configured to attach desired capture molecules via click reactions of azides and alkynes to form polymers with 1,2,3-triazole functional groups. In one embodiment, the capture molecules are selected from the group consisting of aptamers, antibodies, antibody fragments, oligonucleotides, peptides, enzymes, nanobodies, and small molecules.

[0010] In one embodiment, the device further comprises a second FET, which does not comprise a capture molecule; wherein the second FET is configured for differential detection. In one embodiment, a plurality of different capture molecules configured in an array are used to functionalize the device; wherein the device is configured for parallel detection of multiple analytes. In one embodiment, a scanning probe, a scanning electron beam, or a local light source is used to apply a local electromagnetic field to the polymer layer. In one embodiment, the functional group or capture molecule is fixed to the polymer or FET sensing area by a printing method. In one embodiment, the second polymer is deposited on top of the external stimulus-responsive polymer layer, wherein the second polymer is configured as an antifouling coating to reduce the nonspecific binding of the capture molecule outside the sensing area. In one embodiment, the second polymer is removed by a local external stimulus to expose the external stimulus-responsive polymer layer. In one embodiment, the sensing electrode is integrated with the FET on the same chip. In one embodiment, the sensing electrode and the FET are located on different chips; wherein the sensing electrode is configured as an extended gate. In one embodiment, the detection circuit is integrated with the FET. In one embodiment, the detection circuit is separated and manufactured separately from the FET. In one embodiment, the device also comprises a detection circuit integrated in an array of FETs.

[0011] In another aspect, the present invention relates to a method for preparing a biofunctionalized biosensor, comprising: providing a transistor comprising a semiconductor layer; coating the transistor with an external stimulus-responsive polymer layer; applying a local external stimulus to an area of ​​the external stimulus-responsive polymer layer, thereby generating activated functional groups on an area of ​​the surface of the polymer layer; and exposing the polymer layer to capture molecules, wherein the capture molecules are attached to the activated functional groups of the polymer layer. In one embodiment, the local external stimulus comprises heat. In one embodiment, heat is applied using thermal scanning probe lithography (tSPL). In one embodiment, heat is applied using focused light or laser. In one embodiment, the local external stimulus comprises local electromagnetic radiation. In one embodiment, local electromagnetic radiation is applied using a scanning probe, a scanning electron beam, or a local light source.

[0012] In one embodiment, the activated functional group comprises an amine group. In one embodiment, the method further comprises the step of functionalizing the amine to produce a pattern of functional groups, the functional groups being selected from the group consisting of amines, amides, ammonium, maleimides, aldehydes, thiols, biotin, alkynes, cycloalkynes, cyclopropenones, olefins, and azides. In one embodiment, the capture molecule is selected from the group consisting of aptamers, antibodies, antibody fragments, oligonucleotides, peptides, enzymes, nanobodies, and small molecules. In one embodiment, the polymer is produced by free radical polymerization.

[0013] In one aspect, the present invention relates to a method for detecting the presence of an analyte of interest, comprising: providing an apparatus disclosed herein; obtaining a sample; administering the sample to the apparatus; and detecting a change in an FET electrical signal, thereby indicating the presence of a target analyte in the sample. In one embodiment, the target analyte is in a fluid sample. In one embodiment, the target analyte is in an air sample. In one embodiment, the target analyte is selected from the group consisting of: proteins, nucleic acids, protein fragments, antigens, antibodies, surface receptors, hormones, growth factors, cells, viral particles, bacteria, secreted compounds, heavy metals, toxins, toxic molecules, explosives, pollutants, and metabolites. In one embodiment, the sample is a sample obtained from a subject. In one embodiment, the sample is an environmental sample.

[0014] In one aspect, the present invention relates to a method for measuring the concentration of a target analyte in a volume, comprising: providing a biosensor; exposing the biosensor to the volume; periodically measuring the sensor response; when the analyte binds to the capture probe on the surface, calculating the slope of the measured sensor response; and calculating the concentration of the target analyte in the volume based on the slope of the measured sensor response. In one embodiment, the biosensor comprises a sensor surface and at least one surface capture probe. In one embodiment, the step of calculating the slope of the measured sensor response comprises calculating the slope of the sensor response measured during the binding phase multiple times and averaging the calculated slopes. In one embodiment, the biosensor comprises a pulse shaping circuit configured to increase the temporal resolution of the sensor. In one embodiment, the biosensor comprises a pulse shaping circuit configured to reduce noise in the sensor response during the binding phase. In one embodiment, the pulse shaping circuit comprises (CR) n -(RC) m Circuit. In one embodiment, (CR) n -(RC) m The circuit is configured for use in pulse shaping of a signal with a time constant of 1 to 1000 sec. -1 In one embodiment, (CR) n -(RC) m Circuit includes (CR) 2 -(RC) 2 In one embodiment, the step of calculating the slope of the measured sensor response comprises calibrating based on the output of the pulse shaping detection circuit. In one embodiment, the method further comprises the step of calibrating the biosensor for quantifying association and dissociation rate constants.

[0015] In one aspect, the present invention relates to a system for measuring the concentration of a target analyte in a volume, comprising: a biosensor having a sensing surface and an output end, the output end being configured to change an electrical signal based on a response from the sensing surface; and a pulse shaping detection circuit, which is configured to improve the temporal resolution of the sensing and reduce noise in the sensor response during the binding phase. In one embodiment, the pulse shaping detection circuit comprises two first-order high-pass filters having an input and an output connected in series, with the input of the series being electrically connected to the output. In one embodiment, the pulse shaping detection circuit comprises a second-order low-pass filter having an input and an output, the input of the second-order low-pass filter being connected to the output of the series. In one embodiment, the pulse shaping detection circuit comprises a gain stage having an input and an output, the input of the gain stage being connected to the output of the second-order low-pass filter. In one embodiment, the pulse shaping detection circuit comprises (CR) n -(RC) m Circuit. In one embodiment, (CR)n -(RC) m The circuit is configured for use in pulse shaping of a signal with a time constant of 1 to 1000 sec. -1 In one embodiment, (CR) n -(RC) m Circuit includes (CR) 2 -(RC) 2 Circuit. In one embodiment, the pulse shaping detection circuit comprises a plurality of amplification stages along the signal chain. In one embodiment, the electrical signal output of the pulse shaping detection circuit is a predictor of the analyte concentration. In one embodiment, the amplitude of the output of the pulse shaping detection circuit is proportional to the slope of the electrical output signal of the front-end biosensing stage.

[0016] In one embodiment, the front-end sensing stage of the pulse shaping detection circuit comprises a differential amplifier pair of a biosensor. In one embodiment, the output signal of the front-end sensing stage is supplied to the signal chain of the pulse shaping detection circuit. In one embodiment, one biosensor of the differential amplifier pair has a capture probe on its surface. In one embodiment, one biosensor of the differential amplifier pair does not have a capture probe on its surface. In one embodiment, the differential amplifier pair of the biosensor cancels out electrical signals due to non-specific binding. In one embodiment, the differential amplifier pair of the biosensor cancels out ambient noise. In one embodiment, the front-end biosensing stage is a single-stage amplifier. In one embodiment, the output of the front-end biosensing stage is supplied to the signal chain of the pulse shaping circuit. In one embodiment, the biosensor of the front-end amplifier has a capture probe on its surface.

[0017] BRIEF DESCRIPTION OF THE DRAWINGS

[0018] The above objects and features and other objects and features will become apparent with reference to the following description and accompanying drawings, which are included to provide an understanding of the present invention and constitute a part of the specification, wherein like numerals represent like elements, and wherein:

[0019] Figure 1 , Figure 2 and Figure 3 is a diagram of a method for manufacturing a sensor chip;

[0020] Figure 4 is an exemplary biosensor;

[0021] Figure 5 is a plot of the sensor response versus time;

[0022] Figure 6is a diagram of an exemplary FET sensor (see, e.g., Nature Nanotechnology, Vol. 7, pp. 401-407 (2012), which is hereby incorporated by reference in its entirety);

[0023] Figure 7 A graph showing the change in DNA+HMGB1 detection over time at a range of concentrations (see, e.g., Nature Nanotechnology, Vol. 7, pp. 401-407 (2012), which is hereby incorporated by reference in its entirety);

[0024] Figure 8 is an exemplary pulse shaping circuit;

[0025] Fig.9A , Fig. 9B , Fig. 9C , Fig.9D and Fig.9E is a schematic diagram of an exemplary pulse shaping circuit;

[0026] Fig.10 is a graph of simulation results;

[0027] Fig.11A It is a bulk CMOS sensing platform;

[0028] Fig. 11B It is a SOI CMOS sensing platform;

[0029] Fig. 11C It is a FDSOI CMOS sensing platform;

[0030] Fig.12 is an exemplary embodiment featuring air detection of COVID-19;

[0031] Fig.13 Optical images depicting a BioFunFET extended-gate device coated with a thermoresponsive polymer and graphene gate functionalized with Covid-19 antibodies for RBD spike protein detection;

[0032] Fig.14 Describing experimental results of BioFunFET with graphene extended gate for RBD spike protein detection.

[0033] Detailed Description

[0034] It is understood that the drawings and description of the present invention have been simplified to illustrate the elements related to a clear understanding of the present invention, while for the sake of clarity, many other elements found in the related systems and methods have been eliminated. It will be appreciated by those of ordinary skill in the art that other elements and / or steps are desired and / or required when implementing the present invention. However, because such elements and steps are well known in the art, and because they do not promote a better understanding of the present invention, the discussion of such elements and steps is not provided herein. This disclosure relates to all such variations and modifications of such elements and methods known to those skilled in the art.

[0035] definition

[0036] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, exemplary methods and materials are described.

[0037] As used herein, each of the following terms has the meaning associated with it in this section.

[0038] The articles "a" and "an" are used herein to refer to one or to more than one (ie, to at least one) of the grammatical object of the article. By way of example, "an element" means one element or more than one element.

[0039] As used herein, "about" when referring to a measurable value (eg, an amount, a time duration, etc.) is meant to encompass variations of ±20%, ±10%, ±5%, ±1%, and ±0.1% from the stated value, as such variations are appropriate.

[0040] The term "antibody" as used herein refers to an immunoglobulin molecule that is capable of specifically binding to a specific epitope on an antigen. An antibody may be a complete immunoglobulin derived from a natural source or derived from a recombinant source, and may be an immunologically active portion of a complete immunoglobulin. An antibody is typically a tetramer of an immunoglobulin molecule. The antibodies of the present invention may exist in various forms, including, for example, polyclonal antibodies, monoclonal antibodies, Fv, Fab and F(ab)2, as well as single-chain antibodies and humanized antibodies (Harlow et al., 1988; Houston et al., 1988; Bird et al., 1988).

[0041] The term "analyte" refers to a substance to be detected or determined by the method of the present invention. Typical analytes may include, but are not limited to, proteins, peptides, nucleic acid fragments, molecules, cells, microorganisms, and fragments and products thereof, or any substance that can develop an attachment site, binding site, or receptor (e.g., antibody).

[0042] As used herein, "biological sample" means biological material isolated from an individual. A biological sample may contain any biological material suitable for detecting an analyte of interest, and may include cells and / or non-cellular material obtained from an individual.

[0043] As used herein, the term "diagnosis" means detecting a disease or disorder or determining the stage or degree of a disease or disorder. Typically, the diagnosis of a disease or disorder is based on the evaluation of one or more factors and / or indicates the symptoms of the disease. That is, the diagnosis can be based on the presence, absence or amount of a factor, which indicates the presence or absence of a disease or condition. Each factor or symptom considered to indicate a diagnosis of a specific disease does not need to be exclusively related to the specific disease, that is, there can be a differential diagnosis that can be inferred from the diagnostic factor or symptom. Similarly, there may be a situation in which the factor or symptom indicating a specific disease exists in an individual who does not suffer from the specific disease. Diagnostic methods can be used independently or in combination with other diagnostic and / or staging methods known in the medical field for specific diseases or disorders.

[0044] By "level" of one or more analytes of interest is meant the absolute or relative amount or concentration of the analyte in a sample.

[0045] "Measuring" or "measurement" or alternatively "detecting" or "detection" means evaluating the presence, absence, amount or quantity (which may be a significant amount) of a given substance in a sample, including the derivation of the qualitative or quantitative concentration level of such a substance.

[0046] As used herein, "standard control value" refers to a predetermined amount of a specific analyte detectable in a sample. Standard control values ​​are suitable for use with the methods of the present invention in order to compare the amount of a target analyte of interest present in a sample. An established sample serving as a standard control provides an average amount of an analyte of interest in a sample type (e.g., a biological sample) that is typical for an average, healthy person of a reasonably matched background (e.g., sex, age, race, and medical history). Standard control values ​​may vary depending on the properties of the target analyte of interest and the sample.

[0047] The terms "subject", "patient", "individual" and the like are used interchangeably herein and refer to any animal or their cells in vitro or in situ suitable for the methods described herein. In some non-limiting embodiments, the patient, subject or individual is a human.

[0048] Throughout the present disclosure, various aspects of the present invention can be presented in a range format. It should be understood that the description of the range format is only for convenience and brevity, and should not be interpreted as an unchangeable limitation on the scope of the present invention. Therefore, the description of the range should be considered to specifically disclose all possible sub-ranges and single numerical values ​​within the range. For example, the description of a range such as 1-6 should be considered to specifically disclose sub-ranges such as 1-3, 1-4, 1-5, 2-4, 2-6, 3-6, etc., and single numbers within the range, such as 1, 2, 2.7, 3, 4, 5, 5.3, 6 and any full increments and partial increments therebetween. Regardless of the breadth of the scope, this applies.

[0049] Biofunctionalized field effect transistor (biofunFET)

[0050] In one embodiment, the present invention relates to a field effect transistor ( biofunFET The present invention improves upon the prior art of bioFETs by creating a CMOS-compatible biofunFET manufacturing platform that is scalable to a wide variety of biosensing applications, reduces variability, reduces noise, improves sensitivity, reproducibility, and parallel detection, and increases stability and robustness.

[0051] The ability to precisely control the position or localization of molecules / biomolecules on a surface is critical for several applications including biosensing, bionanoreactors, and single-molecule studies. Despite recent advances, the fabrication of functional patterns with single-molecule-level resolution has been limited by the lack of photolithographic methods that combine high resolution, compatibility with soft polymer structures, ease of fabrication, and high throughput.

[0052] In some aspects, the biofunFET of the present invention comprises a FET, and the FET comprises a source electrode, a drain electrode, a gate electrode, and a semiconductor material. In one embodiment, the biofunFET comprises a polymer coated on the FET, wherein such a polymer can be locally activated / patterned and locally functionalized / patterned with any desired chemical molecule. For example, in some embodiments, the polymer is sensitive or responsive to external stimuli (e.g., heat), wherein the local stimulation applied to the specific area of ​​the polymer triggers or activates the formation of functional groups (also referred to herein as "sticky ends") in the desired specific area. In one embodiment, the activated functional groups (e.g., amine groups) of the polymer are used to attach probes or capture molecules (directly or by using other functionalized intermediate steps) to the local thermal activation area of ​​the polymer, thereby functionalizing the biofunFET at a desired position (sensing area), such as a semiconductor region, or a top gate or an extended gate. In sensing measurements, the probe or capture molecule then specifically binds / captures an analyte of interest, so that when the analyte is bound to the probe or capture molecule, a detectable change in the electrical signal of the biofunFET is caused, thereby indicating the presence and quantity of the analyte of interest in the sample. Another possibility is to use an extended gate, where the top gate of the FET is externally electrically connected to a gate coated with a heat (or other local stimulus) sensitive polymer and functionalized to sense the presence of an analyte.

[0053] A "polymer" may be any polymer that can be locally activated by a local external stimulus such as, but not limited to, a local heat source, an electric field, light, current, pressure, shear force. Such activation can be obtained by an external probe such as a nanometer-sized atomic force microscopy tip or beam such as a laser beam, or by direct local deposition of molecules. Local activation generates chemical functional groups on the polymer surface that can be used to attach capture molecules. The activation pattern on the polymer surface can have lateral dimensions ranging from a few picometers to several millimeters.

[0054] In some aspects, the ability to create biofunFETs using localized heating of a coated polymer creates a biofunFET with a CMOS-compatible biofunFET manufacturing platform that can be expanded to a wide variety of biosensing applications while reducing variability and noise, improving sensitivity, reproducibility, and parallel detection, and increasing stability and robustness. For example, in one embodiment, the localized functionalization described in the present invention allows the creation of a device having a functionalized biofunFET (created by localized heating of a coated polymer as described herein) and a non-functionalized FET (which will not have any capture molecules on its sensitive region) next to the sensor FET (see Fig.13). This allows for differential detection because the device will have built-in controls where signals generated by other sources (in addition to the analyte) such as non-specific binding of other molecules to the non-functionalized control FET can be taken into account when measuring / detecting changes in the signal generated by the biofunFET. In addition, local functionalization as described herein allows for the creation of biofunFETs with various patterns of probes or capture molecules on the polymer surface. Still further, local functionalization allows for the ability to perform parallel detection where different probes or capture molecules can be functionalized on the biofunFET to allow for the detection of multiple analytes within a sample / microchip (see Figure 1 ). Because local functionalization by local heat can be achieved at a resolution of 8 nm, the pattern of different capture molecules generated by local heat can be as small as 10 nm. Importantly, because biofunFET can be based on polymer films spin-coated on any electronic device and local heat, this manufacturing platform is fully CMOS compatible, low-cost, robust and reproducible.

[0055] In one embodiment, the biofunFET comprises a semiconductor material. Exemplary semiconductor materials for biofunFETs include, but are not limited to, silicon, carbon nanotubes, III-V and II-VI semiconductors, graphene, 2D materials, MoS2, transition metal dichalcogenides, or other suitable materials.

[0056] In one embodiment, the biofunFET comprises a polymer coated on a semiconductor material or a gate. In some embodiments, the polymer comprises a thermosensitive or thermoresponsive polymer. Any polymer can be used in the present invention, in which local heat or electromagnetic fields cause the generation or activation of functional groups, which can be used to attach probes or capture molecules. For example, in one embodiment, the polymer comprises a thermosensitive or thermoresponsive polymer, wherein the amine group is activated when locally heated. For example, in one embodiment, the polymer comprises a thermosensitive or thermoresponsive polymer, wherein the local heat effectively removes the first functional group from the polymer so that the surface comprises a second functional group at least at a portion of the first position; wherein the first functional group is, for example, but not limited to, tetrahydropyranyl carbamate, amine N-oxide, tetrahydropyranyl ether, trityl ether, tetrahydropyranyl carbonate, S-tetrahydropyranyl carbonyl, or diethyl disulfide; and wherein the second functional group is a thiol, an alcohol, a carboxylic acid and its derivatives, an amine, an alkyne, an aldehyde or a ketone. A tert-butyl ester group can also be used as the first functional group, followed by local deprotection. In one embodiment, a local external stimulus can be used to convert the tert-butyl ester group into a carboxylic acid group. In one embodiment, the resulting carboxylic acid can be further converted into anhydride using additional stimulation (see, for example, "Atomic force microscopybased thermal lithography of poly (tert-butyl acrylate) block copolymer films for bioconjugation." Langmuir 24, 10825-10832 (2008); and "Scanning thermal lithography of tailored tert-butyl ester protected carboxylic acid functionalized (Meth) acry-late polymer platforms." ACS Appl. Mater. Interfaces 3, 3855-3865 (2011)). In other embodiments, the polymer may contain groups that undergo thermal polymerization and crosslinking reactions (including Diels-Alder reactions).

[0057] In some embodiments, the polymer comprises a thermosensitive or thermoresponsive polymer, wherein the amine group is activated upon local heating. Exemplary polymers resulting in activated amines upon local heating include, but are not limited to: poly(methacrylate) copolymers: poly((tetrahydropyran-2-yl N-(2 methacryloyloxyethyl) carbamate)-b-(methyl 4-(3-methacryloyloxypropoxy) cinnamate))(PMCC) (see, e.g., "Sub-10nm Resolution Patterning of Pocketsfor Enzyme Immobilization with Independent Density and Quasi-3D TopographyControl,ACS Applied Materials and Interfaces", 11, 2019; and "Cost and TimeEffective Lithography of Reusable Millimeter Size Bone Tissue Replicas WithSub-15nm Feature Size on A Biocompatible Polymer", Adv.Func.Mater.2021). In addition, for example, in some embodiments, the polymer comprises a thermosensitive or thermoresponsive polymer, wherein the hydroxyl or carboxyl group is activated upon local heating. Exemplary polymers that result in activated hydroxyl or carboxyl groups upon local heating include, but are not limited to: PMCC at elevated temperatures (see, for example, “Sub-10nm Resolution Patterning of Pockets for Enzyme Immobilization with Independent Density and Quasi-3D Topography Control, ACS Applied Materials and Interfaces”, 11, 2019), and copolymers of benzyl methacrylate and THP-MA (which exhibit thermal deprotection of THP groups at about 150°C to produce carboxylic acids and then conversion to anhydrides at greater than 180°C), thermal deprotection of ester groups can produce polymers of carboxylic acid groups.

[0058] In one embodiment, the exposed amines are further functionalized to produce a pattern of functional groups selected from the group consisting of amine, amide, ammonium, maleimide, aldehyde, thiol, biotin, and azide.

[0059] In some embodiments, the polymer is of formula A m -B n -Co , wherein m, n and o are each independently positive integers, A is a crosslinking functional group, B is a monomer residue having a protected functional group that can be deprotected by an external stimulus (e.g., heat or an electromagnetic field), and C is a monomer residue containing a solubilizing group (e.g., an alkyl, alkoxy, or aryl chain) that can increase the solubility of the polymer material. In one embodiment, the bond between the monomer residues A, B, and C is the backbone of the polymer, which is, for example, but not limited to, a poly(methacrylate), poly(acrylate), poly(ester), poly(styrene), poly(amide), or poly(olefin) backbone.

[0060] In one embodiment, C is a short alkyl chain. In one embodiment, C is a short alkoxy chain.

[0061] In one embodiment, B can be tetrahydropyranyl carbamate, amine N-oxide, tetrahydropyranyl ether, trityl ether, tetrahydropyranyl carbonate, S-tetrahydropyranylcarbonyl, or diethyl disulfide. In one embodiment, the different functional groups are amines, alcohols, phenols, or thiols.

[0062] In some embodiments, the polymer comprises poly(p-phenylenevinylene) or poly((tetrahydropyran-2-yl N-(2-methacryloyloxyethyl)carbamate)-co-(methyl 4-(3-methacryloyloxypropoxy)cinnamate)) represented by the formula:

[0063]

[0064] In one embodiment, the polymer is a copolymer such that the polymer backbone comprises two or more polymer components. In one embodiment, the residues A, B and C may be on different components of the polymer backbone. In one embodiment, A comprises a cinnamate group. In one embodiment, B comprises a tetrahydropyranylcarbamate group.

[0065] According to some embodiments, the polymer may be of formula B n Represent, wherein B represents the functional group that will be modified by local external stimulation, n is a positive integer, and the functional group is bonded to the polymer backbone. In one embodiment, B is bonded to the polymer backbone through a polymer side chain. In one embodiment, B is a part of the polymer backbone. In one embodiment, the polymer comprises more than one polymer backbone and / or functional group. In one embodiment, the polymer can be deposited on a substrate using standard film forming techniques (e.g., spin coating, drop casting, scraping and spraying onto a substrate or platform).

[0066] In some embodiments, the polymer backbone may be derived from or may be a monomer such as vinyl, allyl, 4-phenylvinyl, acroyl, epoxide, oxetane, cyclic carbonate, methacroyl, acrylonitrile, etc., which is polymerized by free radical, cationic, atom transfer, or anionic polymerization methods. In some embodiments, the polymer backbone may be derived from or may be an isocyanate, isothiocyanate, or epoxide, which may be reacted with a difunctional amine or alcohol such as HO(CH2) λ OH, H2N(CH2) λ NH2 copolymerization, wherein λ is a positive integer (e.g., 1-25). In some embodiments, the polymer backbone may be derived from or may be a strained ring olefin (e.g., dicyclopentadienyl, norbornene, cyclobutenyl, etc.), which may be polymerized via ring-opening metathesis polymerization using an appropriate metal catalyst, as will be known to those skilled in the art of the present disclosure. In some embodiments, the polymer backbone may be derived from or may be -(CH2) n SiCl3, -(CH2) n Si(OCH2CH3)3, or -(CH2) n Si(OCH3)3, wherein the monomers can react with water under conditions known to those skilled in the art to form a thin film or monolithic organic modified sol-gel glass, or a modified silicated surface, wherein n is a positive integer (e.g., 1-25). In some embodiments, the polymer backbone may be derived from or may be a polymerizable group, which may be photochemically dimerized or polymerized. Such groups may include one or more, and these include, but are not limited to, the following conjugated structures:

[0067]

[0068] In some embodiments, the functional group B can be selected so that when exposed to a local external stimulus, the protective group is removed from the surface, leaving another functional group. For example, to obtain a carboxylic acid, B can be selected from tert-butyl esters, tetrahydropyranyl esters, etc. To obtain an amine, B can include tetrahydropyranyl carbamates, amine N-oxides, etc. If an alcohol or phenol is desired, B can be selected from tetrahydropyranyl ethers, trityl ethers, tetrahydropyranyl carbonates, etc. When a thiol is desired to be exposed to a local external stimulus, B can include S-tert-butyloxycarbonyl, S-tetrahydropyranylcarbonyl, diethyl disulfide, etc.

[0069] In other cases, B may be a group that undergoes thermal polymerization and crosslinking reactions, such as Diels-Alder reactions between two B groups (e.g., furan and maleimide, etc.), ring-opening polymerization (e.g., (polyferrocenylsilane), etc.), ring-opening metathesis polymerization (e.g., dicyclopentadiene, etc.), reactions to form conjugated polymers (e.g., from poly(phenylene vinylene) or other similar precursors), and reactions of trifluorovinyl ethers. In some embodiments, B may be a group that volatilizes or decomposes from treatment with a local external stimulus.

[0070] As mentioned above, the polymer may have more than one functional group B. These functional groups may be chosen so that each B is modified at the same or different temperatures.

[0071] In one embodiment, the polymer may have a group A, which can be photochemically crosslinked or thermally crosslinked to control the softening temperature of the overall polymer. In one embodiment, such a polymer may be represented by formula A m -B n In one embodiment, using the A group, the softening temperature can be adjusted to be higher or lower than the desired chemical modification temperature. In one embodiment, this can be achieved by increasing or decreasing the glass transition temperature and / or crystallinity of the polymer. In one embodiment, the A and B groups can be coupled to the polymer backbone through side chains and can be organized into blocks that can be ordered or randomly oriented. In one embodiment, the A and B groups are derived from the same functional monomer units. In one embodiment, the A and B groups are derived from different functional monomer units. In some embodiments, the A group can be selected from cinnamate, olefins, chalcone, trifluorovinyl ether, Diels-Alder reactants, etc.

[0072] By way of illustration, specific polymers that can be used as surfaces for reacting to topical external stimuli include the following tetrahydropyran- (THP) protected carboxylic acid-functionalized poly (acrylates):

[0073]

[0074] In one embodiment, this type of polymer (which is hydrophobic) can be thermally deprotected at about 120 degrees Celsius (° C.) to generate hydrophilic acid functional groups. In one embodiment, the functional groups will further react at about 170° C. to generate hydrophobic anhydrides. This represents a surface that can undergo a so-called "read-write-overwrite process." It is important to note that the acid to anhydride conversion is reversible by removing and adding water, respectively.

[0075] In one embodiment, another polymer useful for treatment with a local external stimulus is the following poly(amide):

[0076]

[0077] In one embodiment, the starting surface composition (ie, poly(amide)) is hydrophilic; however, it can be modified to a hydrophobic poly(imide) at about 300° C. In one embodiment, the reaction is reversible with the addition of an acid.

[0078] For example, in one embodiment, the polymer comprises a functional group that can be deprotected by a local external stimulus (e.g., heat). In one embodiment, the deprotected functional group in the activated region of the polymer is then reacted using click chemistry to attach the desired capture molecule. In one embodiment, the free thiol groups on the surface revealed by the local external stimulus can undergo thiol-ene click chemistry with olefin-functionalized capture molecules. In one embodiment, the deprotected amine group can be converted into an azide. In one embodiment, the polymer may include an azide as a functional group deprotected by an external stimulus (e.g., heat). In one embodiment, the polymer may include a protected olefin or alkyne, which can be deprotected via a local external stimulus to react with azide-functionalized capture molecules. In one embodiment, thiols, alcohols, and amines can be converted into alkynes or cycloalkynes for participating in copper-catalyzed and / or strain-promoted alkyne azide click chemistry. In one embodiment, the click chemistry reaction yield is high, without the requirement of side reactions, by-products, or harsh reaction conditions. In one embodiment, a 1,3-cycloaddition of a diazide and a diyne can be used to form a poly(arylenetriazole) to initiate a chemical reaction between the functional group and the desired capture molecule. In one embodiment, the exposed functional group is configured to attach the desired capture molecule via a click reaction of an azide and an alkyne to form a polymer with a 1,2,3-triazole functional group.

[0079] For example, in one embodiment, the polymer comprises two acrylate monomers (a crosslinking monomer containing cinnamate and a monomer having a protected amine group that can be deprotected at high temperature) and is formed as a statistical mixture of the two monomers based on the feed ratio using a free radical polymerization method. The formation of other polymer structures such as block copolymers, gradient copolymers, brush copolymers and block copolymers requires a living polymerization method. In order to polymerize the two monomers in a living manner and obtain the polymer structure described above, reversible addition fragmentation (RAFT) polymerization can be used to polymerize the two monomers in a quasi-living manner. The activity of the RAFT polymerization of the two monomers allows the formation of different polymer structures. Block copolymers produce materials with defined crosslinking regions and functionalized parts. In addition, block copolymers from nanostructures on the surface (such as gyroid and lamellar structures) allow pre-defined special distributions of functional groups. Gradient copolymers allow the formation of gradient surface functionalization. Block copolymers produce smaller superstructures on the surface with potential new functionalization schemes. Finally, living polymerization allows complete control of polymer length, degree of polymerization and polydispersity, all variables that affect surface coverage, crosslinking and film-forming properties.

[0080] In one embodiment, the polymer is produced by reversible addition fragmentation (RAFT) polymerization, atom transfer radical polymerization (ATRP), or nitroxide-mediated free radical polymerization.

[0081] In some embodiments, another strategy to adjust the surface properties of the polymer is to expand the monomer. A third monomer containing a solubilizing group (e.g., a short alkyl chain) will increase the solubility of the polymer material during spin coating. This allows the use of higher molecular weight polymers that are soluble and spin-coatable. Finally, under RAFT polymerization conditions, the third monomer will provide further access to new polymer film morphologies and therefore new polymer film properties.

[0082] In one embodiment, the surface may be formed by a self-assembled monolayer or multilayer of molecules. The molecules may be formed by a basic structure X k -RB n , wherein X represents the anchoring group of the molecule to attach to the substrate or platform, R represents the bridging group, C represents the functional group to be modified by the local external stimulus, and k and n are independently positive integers. In one embodiment, these molecules can be processed by standard self-assembled monolayer or multilayer formation techniques, which include thiol-terminated X k -RB n With gold surface, silane-terminated X k -RB n Reactions with glass surfaces or similar reactions.

[0083] In some embodiments, the anchoring group X can be selected from phosphonic acid, phosphinic acid, sulfonic acid, carboxylic acid, carbamate, dithiocarbamate, thiol, selenol, phosphine, amine, amide, carbohydroximic acid, sulfonohydroxamic acid, phosphohydroxamic acid, monochlorosilane, dichlorosilane, trichlorosilane, mono(alkoxy)silane, di(alkoxy)silane, tri(alkoxy)silane, etc., or the conjugate base of any of the above; the bridging group R can be a linear or branched C3-C 50 aliphatic or cycloaliphatic, fluoroalkyl, oligo(ethylene glycol), aryl, amine, and the like; and G can be any of the functional group types discussed above with respect to the polymer surface.

[0084] In one embodiment, the biofunFET includes a second polymer layer on top of the first polymer layer, which can help reduce the nonspecific binding of the probe / capture molecule. For example, in one embodiment, the second polymer layer with low adhesion properties relative to the capture molecule is a thermosensitive or thermoresponsive polymer, wherein local heating evaporates the second polymer layer while also causing the generation or activation of the functional groups required in the first polymer layer. Any polymer with these properties can be used, such as but not limited to polyphthalaldehyde (PPA). Another example is a polymer resist comprising a cyclic, low upper temperature poly (aldehyde). Another example is molecular glass. (See, for example, Microsystems & Nanoengineering (2020) 6: 21, incorporated herein by reference in its entirety).

[0085] In one embodiment, the second polymer is configured as an anti-fouling coating to reduce non-specific binding of capture molecules outside the sensing region. In one embodiment, the second polymer is removed by a local external stimulus to expose the external stimulus-responsive polymer layer.

[0086] In one embodiment, the biofunFET comprises a probe or capture molecule attached to a functional group of a thermosensitive or thermoresponsive polymer. The probe or capture molecule specifically binds to the analyte of interest. Any type of probe or capture molecule known in the art can be used in the present invention, which can be attached to the biofunFET via a functional group, including but not limited to antibodies, aptamers, and peptides.

[0087] The polymer can be selected so that the distance between the probe or capture molecule and the biofunFET surface is such that the association of the analyte of interest with the probe or capture molecule causes a measurable change in the electronic properties of the biofunFET. In some cases, the polymer is selected so that the distance between the capture molecule and the surface of the FET is in the range of 1 to 300 nm.

[0088] In some embodiments, the biofunFET comprises one or more capture molecules that are immobilized on the surface of the FET via a linking group or by direct adsorption to a polymer coating the surface of the FET. In some embodiments, one or more capture molecules are immobilized on the surface of the FET via a linking group (shown by a polymer coating the surface of the FET).

[0089] In some embodiments, the biofunFET comprises a surface coated with a polymer, wherein a local stimulus (e.g., a local heat source) produces a free chemical group or "sticky end" such as a free functional amine, hydroxyl, carboxyl, alcohol, phenol, or thiol or azide. In some embodiments, the "sticky end" serves as an attachment site to attach one or more capture molecules for detecting an analyte of interest. In some embodiments, the biofunFET comprises a surface coated with a thermosensitive polymer, which comprises a group that undergoes a thermal response change (e.g., heat-induced cleavage) such that a free chemical group or "sticky end" (e.g., a free functional amine) is available after thermal activation. In some embodiments, the "sticky end" serves as an attachment site to attach one or more capture molecules for detecting an analyte of interest.

[0090] In some embodiments, the biofunFET comprises a surface coated with a thermosensitive polymer comprising groups that undergo a thermal response change (e.g., thermally induced cleavage) such that free chemical groups or "sticky ends" (e.g., free functional amines, hydroxyls, carboxyls, alcohols, phenols, or thiols or azides) are available upon thermal activation. In some embodiments, the "sticky ends" serve as attachment sites to attach one or more capture molecules for detecting an analyte of interest.

[0091] The biofunFET sensor of the present invention further comprises capture molecules for the analyte of interest immobilized near the surface of the FET such that association of the analyte of interest with the capture molecules causes a measurable change in an electrical property of the FET.

[0092] Capture molecules for specific analytes of interest are known in the art and can be selected in view of many considerations including analyte identity, analyte concentration, and sample properties or sample conditions for the analyte to be detected. Suitable capture molecules include aptamers (nucleic acids or peptides), antibodies, antibody fragments, antibody mimetics (e.g., engineered affinity ligands), peptides (natural or modified peptides), proteins (e.g., recombinant proteins, host proteins), oligonucleotides, DNA, RNA (e.g., microRNA), and small organic molecules (e.g., haptens or enzyme cofactors, enzymes).

[0093] In some embodiments, the capture molecules are bound to activated functional groups of the polymer via biochemical conjugation or electrostatic binding. The binding can occur directly or through the use of intermediate functional groups and linkers.

[0094] In one embodiment, the capture molecules of the present invention comprise antibodies or antibody fragments. In some embodiments, the antibody capture molecules specifically bind to a compound of interest, such as a secreted compound of interest. Such antibodies include polyclonal antibodies, monoclonal antibodies, Fab and single-chain Fv (scFv) fragments thereof, bispecific antibodies, heteroconjugate complexes, human and humanized antibodies.

[0095] Such antibodies can be produced in various ways, including recombinant expression in hybridoma culture, bacteria or mammalian cell culture and recombinant expression in transgenic animals. The choice of manufacturing method depends on several factors, including the desired antibody structure, the importance of carbohydrate structure parts on the antibody, the ease and cost of cultivation and purification. Standard expression techniques can be used to produce many different antibody structures, including full-length antibodies, antibody fragments such as Fab and Fv fragments, and chimeric antibodies comprising components from different substances. Antibody fragments (such as Fab and Fv fragments) of small size without effector functions and limited pharmacokinetic activity can be produced in bacterial expression systems. Single-chain Fv fragments show low immunogenicity.

[0096] In one embodiment, the capture molecules of the present invention comprise isolated nucleic acids, including, for example, DNA oligonucleotides and RNA oligonucleotides. In some embodiments, the nucleic acid capture molecules specifically bind to compounds of interest, such as DNA molecules or RNA molecules (e.g., mRNA, rRNA, or lncRNA). The nucleic acid capture probes of the present invention may be in the form of linear oligonucleotides or may have secondary structures (e.g., hairpins or loops) that promote the binding and capture of target analytes.

[0097] For example, in one embodiment, the nucleic acid comprises a nucleotide sequence complementary to the nucleic acid of interest. The nucleotide sequence of the nucleic acid capture molecule optionally comprises sequence changes relative to the original nucleotide sequence, such as substitutions, insertions and / or deletions of one or more nucleotides, provided that the resulting nucleic acid functions as the original and specifically binds to the compound of interest.

[0098] In one embodiment, nucleic acid comprises nucleic acid aptamers. Nucleic acid aptamers are synthetic oligodeoxynucleotides designed according to strict recognition and binding affinity between nucleotides, and are obtained by screening by systematic evolution of ligands (SELEX) by exponential enrichment. Nucleic acid aptamers not only have features similar to antibodies, such as highly specific recognition and high binding affinity with targets. The aptamers of the present invention may have one or more modified nucleosides or modified core bases connected. For example, in some embodiments, aptamers may be thio aptamers (which contain one or more phosphorothioate or dithiophosphate structural moieties), 2'-fluoro-ribonucleotide oligomers, NH2-substituted and OCH3-substituted ribose aptamers and deoxyribose aptamers. In some embodiments, aptamers may be LNA aptamers.

[0099] The term "capture aptamer" as used herein refers to an aptamer that is bound to a substrate (e.g., a functionalized polymer on a biofunFET) and comprises a configuration that can localize (i.e., bind to in a sample) a target analyte, thereby causing the target analyte to attach to the substrate via the capture aptamer upon binding.

[0100] The term "aptamer" refers to a nucleic acid (typically DNA, RNA or oligonucleotide) that emerges from in vitro selection or other types of aptamer selection procedures well known in the art (e.g., bead-based selection or high-density aptamer arrays using flow cytometry) when the nucleic acid is added to a mixture of molecules. The ligands that bind to the aptamer include, but are not limited to, small molecules, peptides, proteins, carbohydrates, hormones, sugars, metabolic byproducts, cofactors, drugs and toxins. The aptamers of the present invention are specific for a specific target analyte of interest. Aptamers may have diagnostic, target confirmation and therapeutic applications. The specificity of binding is defined in terms of the dissociation constant Kd of the aptamer for its ligand. Aptamers may have high affinity, with a Kd range similar to that of antibodies (pM to nM) and specificity similar to / better than that of antibodies (Tuerk and Gold, 1990, Science, 249:505; Ellington and Szostak, 1990, Nature 346:818). Aptamers will typically be between 10 and 300 nucleotides in length.

[0101] An aptamer configured to bind to a specific target analyte can be selected, for example, by synthesizing an initial heterogeneous population of oligonucleotides and then selecting oligonucleotides within the population that bind tightly to the specific target analyte. Once an aptamer that binds to a specific target molecule has been identified, it can be replicated using various techniques known in biology and other fields, such as by cloning and polymerase chain reaction (PCR) amplification followed by transcription.

[0102] In some embodiments, the thermally activated functionalization of the polymer-coated surface can be limited in time, space, or both in time and space, so that only a portion of the polymer (e.g., a single area or pattern) is functionalized for attachment to capture molecules at a given time or at a given location on the surface of the FET (e.g., an extended gate or channel of the FET). Such embodiments allow the creation of multi-probe biofunFET sensors (in which different capture molecules are functionalized in different areas across the surface of the sensor) or multiplexed sensors (in which different samples can be applied to different areas of the sensor).

[0103] Also provided are devices, including probes and multiwell plates, incorporating the biofunFET sensors of the present invention.

[0104] In one embodiment, the present invention relates to a method for producing a biofunFET as described herein. In one embodiment, the method comprises coating the semiconductor material of the FET with a thermosensitive or thermoresponsive polymer. For example, in one embodiment, the method comprises spin coating the semiconductor material of the FET with a thermosensitive or thermoresponsive polymer. Other examples include, but are not limited to, physical vapor deposition, chemical vapor deposition, sputtering, or other suitable methods.

[0105] As described herein, localized heat applied to the polymer triggers the creation or activation of functional groups to which probes or capture molecules can then attach.Any localized heat source can be used and applied to the polymer surface.

[0106] For example, in one embodiment, the method includes heating or activating the polymer surface using an electromagnetic field, such as a laser, electron beam, electric field, or other suitable method.

[0107] In one embodiment, the method includes using thermal scanning probe lithography (tSPL) to locally heat the polymer surface. tSPL (R. Szoszkiewicz et al., Nano Lett. 2007, 7, 1064) has been shown to be able to pattern complex quasi-3D topography (quasi-3Dtopographies) on polymer surfaces with a lateral resolution of less than 15 nm and a depth resolution of less than 2 nm (D. Pires et al., Science 2010, 328, 732; R. Garcia et al., Nat. Nanotechnol. 2014, 9, 577; XY Liu et al., ACS Appl. Mater. Interfaces 2019, 11, 41780). tSPL can be performed using commercially available instruments that use a thermal nanoprobe to locally evaporate the thermosensitive polymer polyphthalaldehyde (PPA), leaving a void of defined pixel size (ST Zimmermann et al., ACS Appl. Mater. Interfaces 2017, 9, 41454; ST Howell et al., Microsyst. Nanoeng. 2020, 6, 21; XR Zheng et al., Nat. Electron. 2019, 2, 17). In one embodiment, a scanning probe, a scanning electron beam, or a local light source is used to apply local electromagnetic radiation to the polymer layer.

[0108] tSPL can write topographical and chemical features in a heat-sensitive polymer resist by local heating, thereby engraving and chemically activating the surface with nanometer-scale precision (XY Liu et al., ACS Appl. Mater. Interfaces 2019, 11, 41780; DB Wang et al., Adv. Funct. Mater. 2009, 19, 3696). The tSPL method first involves pixelation of a reference input image, and then replicates the image by assigning a specific height level at each gray level of a single pixel. Additional information about tSPL and other lithography techniques can be found in U.S. Patent Application No. 17 / 592,169 filed on February 3, 2022 and U.S. Patent No. 8,468,611 published on June 18, 2013, which are incorporated herein by reference in their entirety.

[0109] In one embodiment, the method comprises functionalizing the FET by attaching one or more reagents or capture molecules to generated or activated functional groups (generated by local heating of the polymer). In one embodiment, the method comprises contacting the surface of the polymer with a liquid medium containing a probe or capture reagent, wherein the probe or capture reagent is bound to or otherwise associated with the functional group of the polymer.

[0110] FIG. 9 provides an exemplary method for producing a disclosed biofunFET, where a polymer can be spin coated onto a transistor, where a localized heat source is then used to change the surface chemistry and produce a "sticky" amine nanopattern on the transistor. The aptamers then stick only to the patterned amines. In some embodiments, the polymer pattern can be used with different types of aptamers for sensing multiple analytes. In this way, a control FET is produced on the same chip. Figure 2 Neutralization Figure 3 Another view of the production method is shown in FIG. Figure 1 The steps correspond to Figure 2 Steps marked A) and B) in the figure.

[0111] A new sensing platform is disclosed herein, which includes the integration of the above tSPL patternable polymers with electronic and optoelectronic devices, which in some embodiments can utilize the sensing methods described above. This integration involves placing the polymer on top of a sensor (e.g., an electronic sensor, a magnetic sensor, and / or an optical sensor), and then locally nanopatterning by local heating, tSPL, nanopatterning methods, or other heat sources (e.g., lasers) to functionalize the target area. The novel features of the platform include, but are not limited to, selective attachment of molecules and biomolecules to the desired active area of ​​the sensor after sensor fabrication, such as via patterning of voids or thinner areas of a polymer or other covering material (e.g., a masking polymer) positioned above the sensor active area.

[0112] In some embodiments, the spatial density distribution of molecules on the surface of the sensing platform can be controlled and made consistent across all sensors in the sensing platform. In some embodiments, functionalized patterns of arbitrary shapes can be fabricated with spatial resolutions as low as 10 nm, less than 1 μm, less than 500 nm, less than 200 nm, less than 100 nm, less than 50 nm, less than 20 nm, less than 10 nm, less than 8 nm, less than 5 nm, or less than 3 nm in the sensor active area.

[0113] In some embodiments, sensor performance (limit of detection) can be controlled by the thickness of the polymer, where the polymer thickness can be controlled down to a single monolayer, in increments of, for example, one, two, three, five, or ten monolayers. The polymer thickness can range from 1 nm to 300 nm. In some embodiments, multiple biomolecules can be attached and sensed in the same electronically active region in some embodiments. In some embodiments, the limit of detection can range from femtomolar to nanomolar.

[0114] The disclosed platform is a general approach across different sensing platforms, devices, and materials to achieve such functionalization.

[0115] In some embodiments, disclosed herein are methods of producing a patterned or customized sensing surface, comprising: providing a sensor having an active sensing area, positioning or depositing a masking material (e.g., a polymer) having a deposited thickness or thickness range over the active sensing area, determining a desired sensing surface profile, and photolithographically patterning a set of voids or thin regions having a thickness less than the deposited thickness or thickness range in the masking material, such that the voids or thin regions, respectively, form exposed or partially exposed regions of the sensing surface configured to act as the desired sensing surface profile. The size of the active sensing area may range from several 100 nm to several 100 nm. 2 To several thousand mm 2 .

[0116] The apparatus and methods of the present invention can be used to determine the presence and / or quantity of any target analyte. Suitable types of analytes include proteins, nucleic acids, protein fragments, antigens, antibodies, surface receptors, hormones, growth factors, cells, viral particles, bacteria, secreted compounds, metabolites, etc. The precise combination of compounds of interest measured by the methods of the present invention can be easily controlled and limited by the end user. For example, the detection of specific target analytes is limited only by the availability of capture reagents (e.g., antibodies, aptamers, peptides, nucleic acid sequences, etc.), which specifically bind to compounds and can be functionalized to the biofunFET surface. In one embodiment, the capture molecule comprises an antibody or a capture aptamer, and the target analyte comprises an area or epitope to which the antibody or capture aptamer binds.

[0117] In one embodiment, the method of the present invention includes the following steps: obtaining a sample that contains or may contain a target analyte, contacting a biofunFET comprising a capture probe of the present invention for detecting the target analyte with at least a portion of the sample, detecting a change in potential based on the interaction between the target analyte in the sample and the capture probe on the biofunFET, and confirming that the sample contains the target analyte based on the detected change in potential.

[0118] On the one hand, the sample can be contacted with the biofunFET so that the target analyte present in the sample is bound to the capture probe on the biofunFET. On the one hand, the present invention relates to a method for detecting the presence or abundance of an analyte of interest using a biofunFET as described herein and a sensor or device comprising the biofunFET. The present invention can be used to detect the presence or abundance of any analyte of interest. Because any probe or capture molecule can be functionalized using the activated functional group of the polymer, the probe or capture molecule can be selected to specifically bind to the analyte of interest.

[0119] The parallel detection capabilities of the present invention allow for the detection of 2 or more, 3 or more, 4 or more, 5 or more, 10 or more, 20 or more, 40 or more, 50 or more, 100 or more, etc. target analytes in one or more samples. For example, as described elsewhere herein, the spatial functionalization of the heat-activated polymers provided by the present invention allows for the ability to create distinct regions for parallel capture and detection of analytes.

[0120] In some embodiments, the method includes detecting the presence or abundance of an analyte in a sample obtained from a subject to detect the presence or severity of a disease, disorder, or condition in the subject. For example, in some embodiments, the method can be used to diagnose a subject as having or at risk of having a disease, disorder, or condition. In one embodiment, the method is used to determine that a subject has a pathogen infection (e.g., a viral infection or a bacterial infection).

[0121] In one embodiment, the present invention provides a method for diagnosing a subject as having an infection or a disease or disorder associated therewith, based on the detection of one or more target molecules associated with an infectious agent (e.g., a virus, bacteria, fungus, or protozoa). In one embodiment, the present invention provides a method for determining the risk of developing an infection or a disease or disorder associated therewith or evaluating the progress thereof by detecting the presence of at least one target molecule in a sample.

[0122] In some embodiments, the target analyte comprises a virus particle, including but not limited to coronavirus, influenza virus, Zika virus, Ebola virus, Japanese encephalitis virus, mumps virus, measles virus, rabies virus, varicella-zoster, Epstein-Barr virus (HHV-4), cytomegalovirus, herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2), human papillomavirus (HPV), human immunodeficiency virus-1 (HIV-1), JC virus, arbovirus, enterovirus, West Nile virus, dengue virus, poliovirus and varicella-zoster virus. In some embodiments, the target analyte comprises a bacterial marker, including but not limited to a marker of Streptococcus pneumoniae, Neisseria meningitidis, Streptococcus agalactiae or Escherichia coli. In some embodiments, the target analyte comprises a fungal or protozoan marker, including but not limited to a marker of candidiasis, aspergillosis, cryptococcosis and toxoplasma.

[0123] In one embodiment, the method of the present invention is a method for diagnosing a disease or disorder associated with the presence or absence of a target analyte. In one embodiment, the method comprises the following steps: obtaining a sample from a subject suffering from or at risk of a disease or disorder associated with the presence of a target analyte, contacting a biofunFET comprising a capture probe for detecting a target analyte with at least a portion of the sample, detecting a change in potential based on the interaction of the target analyte in the sample with the capture probe on the biofunFET, confirming that the sample contains the target analyte based on the detection of the change in potential, and diagnosing the subject as suffering from a disease or disorder associated with the presence of a target analyte. In one embodiment, the method comprises the following steps: obtaining a sample from a subject suffering from or at risk of a disease or disorder associated with the absence of a target analyte, contacting a biofunFET comprising a capture probe for detecting a target analyte with at least a portion of the sample, detecting no potential change based on the absence of the target analyte and the capture probe on the biofunFET, confirming that the sample is lacking the target analyte based on the detection of no potential change, and diagnosing the subject as suffering from a disease or disorder associated with the absence of a target analyte.

[0124] In one embodiment, the method of the present invention is a method for treating a disease or disorder associated with the presence or absence of a target analyte. In one embodiment, the method comprises the following steps: obtaining a sample from a subject suffering from or at risk of suffering from a disease or disorder associated with the presence of a target analyte, contacting a biofunFET comprising a capture probe for detecting the target analyte with at least a portion of the sample, detecting a change in potential based on the interaction of the target analyte in the sample with the capture probe on the biofunFET, confirming that the sample contains the target analyte based on the change in detected potential, confirming that the subject suffers from a disease or disorder associated with the presence of a target analyte, and administering a therapeutic agent for treating a disease or disorder associated with the presence of a target analyte. In one embodiment, the method includes the steps of obtaining a sample from a subject having or at risk for a disease or disorder associated with the absence of a target analyte, contacting a biofunFET comprising a capture probe for detecting the target analyte with at least a portion of the sample, detecting the absence of a potential change based on the absence of interaction of the target analyte with the capture probe on the biofunFET, confirming the sample as lacking the target analyte based on detecting the absence of a potential change, confirming the subject as having a disease or disorder associated with the absence of the target analyte, and administering a therapeutic agent for treating the disease or disorder associated with the absence of the target analyte.

[0125] exist Fig.12 An exemplary embodiment featuring air detection of COVID-19 is shown in . In such an embodiment, an air sample suspected of containing SARS-CoV-2 viral particles is mixed with a liquid and applied to a biofunFET sensor of the present invention, which is functionalized with an aptamer specific for binding to a SARS-CoV-2 antigen.

[0126] Therefore, in one embodiment, the present invention provides a method for diagnosing a subject as having SARS-CoV-2 infection or a disease or disorder associated therewith (e.g., COVID-19). In one embodiment, the present invention provides the following method: determining the risk of developing or evaluating the progress of SARS-CoV-2 infection or a disease or disorder associated therewith (e.g., COVID-19) by detecting SARS-CoV-2 antigens or nucleic acid molecules in a sample.

[0127] Fig.13 Optical image depicting a BioFunFET extended-gate device coated with a thermoresponsive polymer and the graphene gate functionalized with Covid-19 antibodies for RBD spike protein detection. Fig.14 Describes the experimental results of BioFunFET with graphene extended gate for RBD spike protein detection, which shows that after RBD is detected by the sensor, VT offset.

[0128] In some embodiments, the method includes detecting the presence or abundance of an analyte in an environmental sample (eg, a water sample, a sewage sample, an air sample, etc.) to determine the presence of the analyte within the environment.

[0129] In some embodiments, the method includes detecting a change in the electrical properties of a biofunFET, wherein the change indicates the presence of an analyte of interest. As described herein, in some embodiments, the sensor currently described reduces noise by having a functionalized biofunFET and an unfunctionalized FET, thereby allowing more accurate determination and quantification of the presence of analytes in a sample. In a specific embodiment, the electrical signal of a biofunFET is analyzed using a rapid sensing method described in more detail below. However, biofunFETs and methods of use are not particularly limited to any analytical method.

[0130] The disclosed device and method include three key advantages. The first is to biofunctionalize by local heating of a specific (ad-hoc) polymer spin-coated onto the FET. This provides a robust chemical functionalization of the biofunFET, allowing it to be compatible with CMOS (complementary metal oxide semiconductor), FDSOI (fully depleted silicon on insulator) and DG FDSOI (dual-gate fully depleted silicon on insulator) (which is advantageous for the microelectronics industry) and allows local functionalization of different sensing, resulting in a substantial increase in signal-to-noise ratio and reproducibility. In some embodiments, parallel sensing capabilities can be achieved, for example, via sequential activation of polymers, for sensing multiple analytes or viruses on the same biochip. Local heating can be obtained in CMOS, which allows local and on-demand functionalization. DG FDSOI has two independent gates for device-level "capacity" amplification. In some embodiments, only a portion of the polymer is functionalized, and the unfunctionalized portion is used as a control.

[0131] The second advantage is rapid detection using transient response as disclosed herein, in contrast to steady-state measurement methods where the response time (time to steady state) depends on the concentration of the sample measured. Lower concentrations require longer times to reach steady state. The third advantage is that aptamers are cheap, allowing easier functionalization and adaptation of biofunFETs to new viruses and bacteria, and have strong kinetics for rapid detection.

[0132] Rapid biosensing

[0133] In one aspect, CMOS biochips and methods for rapid sensing applications are disclosed herein. Figure 4. The biosensor includes a sensor surface 103 functionalized with one or more capture probes 102 for detecting at least one target analyte. Target analyte 101 is shown bound or unbound to surface probe 102. Target analyte 101 plus surface probe 102 produce chemical specific detection. The combination of target analyte 101 and surface probe 102 results in a signal generated by sensor 103. Exemplary target analytes that can be detected include those described elsewhere herein.

[0134] refer to Figure 5 , showing a graph of sensor response 202 over time in a typical test. In some embodiments, the sensor response is measured in volts. The sensing moves from an initial move to a region represented by (I), which occurs when the analyte 101 begins to bind to the surface probe 102. The first stage is defined by a transient state to a steady state in a second region represented by (II). The kinetics can be determined in some embodiments using a two-compartment model defined in the following equation 1:

[0135]

[0136] where k1 is the association rate constant, k -1 is the dissociation rate constant, and k M is the effective transfer rate constant. In such a scheme, the sensor response time is (t1-t0) and the maximum time resolution in Hz is (t1-t0) -1 .

[0137] Region II is defined as the steady-state region, in which conventional detection is performed. Once the measured signal is sufficiently constant, the sensor value is recorded. In this way, only one measurement is possible for determining the concentration of the analyte.

[0138] Finally, region III is the dissociation region, which corresponds, for example, to sensor rinsing, wherein the analyte particles are removed from the sensor surface and the sensor is ready for the next measurement.

[0139] The key discovery of the present disclosure is that the rise time (shown by the broken line box 201) increases with the reduced analyte concentration (and conversely decreases with the increased analyte concentration). Therefore, the measurement of the rise time can be used to calculate the concentration more quickly. By adjusting the parameters of the appropriate circuit described in the subsequent embodiments, the detection time can be from a few seconds to sub-seconds. In some embodiments, the rise time measurement can be a less accurate prediction value, and therefore multiple measurements using either multiple sensors in parallel or sequential measurements using one sensor can be used to improve accuracy. These two approaches themselves have the disadvantages of spatial resolution and temporal resolution loss, respectively.

[0140] Figure 6and Figure 7 Examples of using FET sensors are shown in and further described in Nature Nanotechnology, Vol. 7, pp. 401-407 (2012), which is hereby incorporated by reference in its entirety. Figure 6 An exemplary FET sensor is shown in FIG. Figure 7 A graph showing DNA+HMGB1 detection over time at a range of concentrations is shown - curve 401 corresponds to 500 nM, curve 402 corresponds to 400 nM, curve 403 corresponds to 300 nM, curve 404 corresponds to 200 nM, curve 405 corresponds to 150 nM, curve 406 corresponds to 100 nM, curve 407 corresponds to 50 nM, curve 408 corresponds to 30 nM, and curve 409 corresponds to 3 nM. As shown, the time resolution at 3 nM is less than 0.33 Hz.

[0141] According to the two-compartment model, when the analyte / surface probe reaction is not mass transfer limited (i.e., the mass transfer coefficient is large), the transient is an exponential function and depends on the association rate constant (k1) and the analyte concentration [A]. One aspect of the present disclosure is to use the basic principles of analyte / surface probe reaction kinetics to predict the analyte concentration from the slope of the transient curve. This principle can be applied to all sensing modalities and sensor types in some embodiments.

[0142] The disclosed method is advantageous because it improves time resolution, and in some embodiments the disclosed measurement results scheme can also be applied multiple times during the transient time of the same "A+B" reaction (i.e., t1-t0 time scale). This allows averaging to reduce errors and improve confidence.

[0143] An example is presented below with respect to a FET sensor. The output V(t) of the FET sensor is given by Equation 2 below.

[0144]

[0145] Where V eq Determined via calibration and dependent on the sensor type, the steady state value of the threshold voltage shift for a given analyte concentration [A] is given by the following Equation 3:

[0146]

[0147] Expanding V(t) using the Taylor series yields the following equation 4:

[0148]

[0149] where α and τ are given by Equation 5 and Equation 6, respectively.

[0150]

[0151] The differential of V(t) can then be used to determine the concentration based on the slope of the transient (rise time portion, region I) of the sensor response curve.

[0152] In some embodiments, a pulse shaping circuit can be used to condition the sensor output, e.g. Figure 8 In some embodiments, the pulse shaping circuit is designed to be insensitive to noise in the sensor response, particularly in the t0-t1 region I and / or the initial sensor response region 201. In some embodiments, using (CR) n -(RC) m Pulse shaping circuits. These circuits are used in particle detectors for high energy physics (which have a time scale of μs). Such circuits can be configured for use in pulse shaping of signals with a time constant of 1 to 1000 sec. -1 In some embodiments, to accommodate such low signals, the time constants of the high-pass and low-pass filters are adjusted accordingly and large resistors in the Ohm range are used. In some embodiments, to allow on-chip integration of these circuits, pseudo resistors are used to achieve the desired time constants. In some embodiments, m=n=2. In some embodiments, m and / or n are less than or equal to 4.

[0153] In some embodiments, the front-end sensing stage of the detection circuit includes a differential amplifier pair of a biosensor. In some embodiments, the output signal of the front-end sensing stage is supplied to the signal chain of the pulse shaping circuit. In some embodiments, one biosensor of the differential amplifier pair has a capture probe on its surface. In some embodiments, one biosensor of the differential amplifier pair does not have a capture probe on its surface. In some embodiments, the differential amplifier pair of the biosensor cancels out the electrical signal due to non-specific binding. In some embodiments, the differential amplifier pair of the biosensor cancels out environmental noise. In some embodiments, the pulse shaping detection circuit includes multiple amplification stages along the signal chain. In some embodiments, the front-end biosensing stage is a single-stage amplifier. In some embodiments, the output of the front-end biosensing stage is supplied to the signal chain of the pulse shaping circuit. In some embodiments, the biosensor of the front-end amplifier has a capture probe on its surface. In some embodiments, the electrical signal output of the pulse shaping detection circuit is a predicted value of the analyte concentration. In some embodiments, the amplitude of the output of the pulse shaping detection circuit is proportional to the slope of the electrical output signal of the front-end biosensing stage.

[0154] Assumption (CR) 2 -(RC) 2The analytical model for predicting the peak value of the voltage output of the shaping circuit is given in Equation 7 and Equation 8 below. Equation 7 is used for (CR) 2 -(RC) 1 shaping circuit, and Equation 8 for (CR) 2 -(RC) 2 Shaping circuit.

[0155]

[0156] Fig.9A An exemplary shaping circuit for use with the disclosed system is shown in FIG. 1 , wherein the detailed diagram shown is as follows: Fig. 9B The current generator in Fig. 9C The two first-order high-pass filters shown in Fig.9D The second order low pass filter shown in Fig.9E In some embodiments, all GΩ resistors (shown as white ovals) are replaced by active resistors or pseudo resistors. In some embodiments, the gain stage is implemented by a PGA (Programmable Gain Amplifier).

[0157] use Fig.9A The simulation results of the shaping circuit are Fig.10 As shown in L = 0.1s and τ H =0.3s.

[0158] In some embodiments, the extreme value P is used using a low pass filter and a high pass filter respectively. L and P H The peak value is determined by an analytical model of k1. In some embodiments, once calibrated, the determined peak value is related to the concentration and can therefore be used to determine the concentration. In some embodiments, according to Equation 8, the peak amplitude is inversely proportional to τ, where τ (according to Equation 5) depends on k1, k -1 and [A].

[0159] exist Fig.11A , Fig. 11B and Fig. 11C Three exemplary structures are shown in FIG. 5 (in which the biofunFET is monolithically integrated with the CMOS readout circuitry). Fig.11A The main CMOS sensing platform is shown. Fig. 11B shows the SOI CMOS sensing platform, and Fig. 11C Shown is a FDSOI CMOS sensing platform.

[0160] exist Fig.11A , Fig. 11B and Fig. 11CIn the diagram, the letter "S" represents source, the letter "D" represents drain, the letters "TG" represent top gate, the letters "BG" represent bottom gate, the letters "G" represent gate and the letters "DG" represent dual gate. "Sensing pixel" refers to biofunFET + readout circuit. "SOI" refers to silicon on insulator. "Target" is the target molecule, virus, etc. "BOX" refers to buried oxide. Vg is the gate bias voltage. REF is the reference electrode.

[0161] exist Fig.11A , Fig. 11B and Fig. 11C In various embodiments, the biofunFET can have a single gate for SOI and bulk CMOS technologies. The biofunFET can operate in a single or dual gate configuration in FDSOI technology. Monolithically, the biofunFET is made of silicon in these structures. In some embodiments, the biofunFET can be heterogeneously integrated on top of a fully fabricated CMOS chip.

[0162] In some structures, the biofunFET can be made of different functional semiconductors. In addition, the heterogeneously integrated biofunFET can be operated in a single or dual gate configuration. In some disclosed structures, a CMOS integrated heater or an external heat source (e.g., a thermal scanning tip, a laser, etc.) can be used to locally functionalize the polymer located above the sensing surface.

[0163] system

[0164] In one embodiment, the invention provides a system comprising biofunFET of the present invention, CMOS chip or their combination. In some embodiments, the system comprises a computing device. The computing device may include a desktop computer, a notebook computer, a tablet computer, a smart phone or other equipment and include a software platform for controlling system components, displaying raw data and analyzing data. The computing device may include at least one processor, a standard input and output device and all hardware and software typically found on a computing device for storing data and running a program and for sending and receiving data on a network.

[0165] In some embodiments, the system of the present invention comprises hardware and software that detects and quantifies the detection signal from the biofunFET or CMOS chip. Any suitable analysis software package or customized analysis algorithm can be used to quantify the signal.

[0166] The disclosure of each patent, patent application and publication cited herein is hereby incorporated by reference in their entirety. Although the present invention is disclosed with reference to specific embodiments, it is apparent that other embodiments and variations of the present invention may be designed by other skilled in the art without departing from the true spirit and scope of the present invention. The appended claims are intended to be interpreted as including all such embodiments and equivalent variations.

[0167] References

[0168] The following publications are incorporated herein by reference in their entirety.

[0169] X. Liu et al., Sub-10nm Resolution Patterning of Pockets for EnzymeImmobilization with Independent Density and Quasi-3D Topography Control, ACSApplied Materials and Interfaces, 11, 2019

[0170] X.Liu et al., Cost and Time Effective Lithography of Reusable MillimeterSize Bone Tissue Replicas With Sub-15nm Feature Size on A BiocompatiblePolymer, Adv.Func.Mater.2021

[0171] D.Wang et al., Thermochemical Nanolithography of Multifunctional Nanotemplates for Assembling Nano-Objects, Adv.Func.Mater., 2009

[0172] T. Wu et al., Experimental Study of the Detection Limit in Dual-GateBiosensors Using Ultrathin Silicon Transistors, ACS Nano, 2017

[0173] E. Cuniberto et al., Nano-engineering the material structure of preferentially oriented nano-graphitic carbon for making high-performance electrochemical micro-sensors, Scientific Reports, 2020

[0174] X. Zheng et al., Patterning metal contacts on monolayer MoS2 with vanishing Schottky barriers using thermal nanolithography, Nature Electronics, 2019。

Claims

1. A device comprising a functionalized biosensor for detecting the presence of an analyte, comprising: A field effect transistor (FET) coated with an external stimulus-responsive polymer layer, wherein the external stimulus-responsive polymer layer is configured to be locally modified via a local external stimulus to expose chemical functional groups in a desired sensing area of ​​the device, the chemical functional groups being configured to attach to capture molecules.

2. The device of claim 1, wherein the thermo-responsive polymer comprises a first functional group and a second functional group, wherein the external stimulus removes the first functional group from the polymer such that a second activated functional group is exposed.

3. The apparatus of claim 2, wherein the first functional group comprises at least one of a tetrahydropyranyl carbamate, an amine N-oxide, a tetrahydropyranyl ether, a trityl ether, a tetrahydropyranyl carbonate, an S-tetrahydropyranyl carbonyl, a diethyl disulfide, a cyclopropenone, and a tert-butyl ester group, and wherein the second activated functional group comprises at least one of an amine, an alcohol, a phenol, or a thiol.

4. The device of claim 2, wherein the second functional group is an amine.

5. The device according to claim 1, wherein the polymer is of formula A m -B n express; Wherein m and n are independently positive integers; A is a monomer residue containing a cross-linking functional group; B comprises a monomer residue having a protected functional group, which can be deprotected by an external stimulus; and Wherein A and B are each attached to a polymer backbone.

6. The device according to claim 1, wherein the polymer is of formula A m -B n -C o express; Wherein m, n and o are independently positive integers; A is a monomer residue containing a cross-linking functional group; B comprises a monomer residue having a protected functional group, which can be deprotected by an external stimulus; and C is a monomer residue containing a solubilizing group; Wherein A, B and C are each attached to the polymer backbone.

7. Apparatus according to claim 5 or claim 6, wherein A comprises methyl cinnamate.

8. The apparatus of claim 5 or claim 6, wherein B comprises at least one of a tetrahydropyranyl carbamate, an amine N-oxide, a tetrahydropyranyl ether, a trityl ether, a tetrahydropyranyl carbonate, an S-tetrahydropyranyl carbonyl, a diethyl disulfide, a cyclopropenone, and a tert-butyl ester group.

9. The device of claim 6, wherein C comprises an alkyl, alkoxy or aryl chain.

10. The device of claim 5 or claim 6, wherein the polymer backbone comprises one or more polymers selected from the group consisting of poly(methacrylates), poly(acrylates), poly(esters), poly(styrenes), poly(amides), poly(olefins), and combinations, copolymers, statistical copolymers, gradient copolymers, or block copolymers thereof.

11. The apparatus of claim 1, wherein the polymer is produced by reversible addition fragmentation (RAFT) polymerization, atom transfer radical polymerization (ATRP), or nitroxide-mediated radical polymerization.

12. The device of claim 1, wherein the external stimulus is heat and the polymer is thermoresponsive.

13. The device of claim 1, wherein the functional groups are generated or activated upon localized heating of the thermoresponsive polymer.

14. The apparatus of claim 1, wherein the local external stimulus comprises electromagnetic radiation.

15. The device of claim 1, wherein the exposed functional groups comprise functional groups selected from the group consisting of thiols, alcohols, carboxylic acids and derivatives thereof, amines, alkynes, aldehydes, and ketones.

16. The apparatus of claim 1, wherein the exposed functional groups are further converted into alkyne, azide, cycloalkyne, cyclopropenone groups.

17. The device of claim 1, wherein the exposed functional groups are configured to attach desired capture molecules using a click chemistry reaction selected from the group consisting of thiol-ene, thiol-alkyne, copper-catalyzed alkyne-azide cycloaddition, strain-promoted alkyne-azide cycloaddition, sulfur-fluoride exchange, and Diels-Alder reaction.

18. The device of claim 1, wherein the exposed functional groups are configured to attach desired capture molecules via a click reaction of azide and alkyne to form a polymer with 1,2,3-triazole functional groups.

19. The device of claim 1, wherein the capture molecule is selected from the group consisting of aptamers, antibodies, antibody fragments, oligonucleotides, peptides, enzymes, nanobodies, and small molecules.

20. The device of claim 1, wherein the device further comprises a second FET, the second FET not comprising a capture molecule; wherein the second FET is configured for differential detection.

21. The device of claim 1, wherein the device is functionalized with a plurality of different capture molecules arranged in an array; wherein the device is configured for parallel detection of multiple analytes.

22. The apparatus of claim 1, wherein a scanning probe, a scanning electron beam, or a localized light source is used to apply a localized electromagnetic field to the polymer layer.

23. The device according to claim 1, wherein the functional groups or capture molecules are immobilized on the polymer or FET sensing area by a printing method.

24. The device of claim 1, wherein a second polymer is deposited on top of the outer stimuli-responsive polymer layer, wherein the second polymer is configured as an anti-fouling coating to reduce non-specific binding of capture molecules outside the sensing area.

25. The device of claim 24, wherein the second polymer is removed by the local external stimulus to expose the external stimulus-responsive polymer layer.

26. The device of claim 1, wherein a sensing electrode is integrated with the FET on the same chip.

27. The device of claim 1, wherein a sensing electrode is located on a different chip than the FET; wherein the sensing electrode is configured as an extended gate.

28. The device of claim 1, wherein a detection circuit is integrated with the FET.

29. The device of claim 1, wherein the detection circuit is separate and fabricated separately from the FET.

30. The apparatus of claim 1, further comprising a detection circuit integrated within the array of FETs.

31. A method for preparing a biofunctionalized biosensor comprising: providing a transistor including a semiconductor layer; coating the transistor with an external stimulus-responsive polymer layer; applying a local external stimulus to a region of the external stimulus-responsive polymer layer, thereby generating activated functional groups on a region of the surface of the polymer layer; and The polymer layer is exposed to capture molecules, wherein the capture molecules are attached to the activated functional groups of the polymer layer.

32. The method of claim 31, wherein the local external stimulus comprises heat; wherein the heat is applied using thermal scanning probe lithography (tSPL).

33. The method of claim 31, wherein the local external stimulus comprises local heat.

34. The method of claim 33, wherein the local external stimulus comprises heat; wherein the heat is applied using focused light or laser.

35. The method of claim 31, wherein the local external stimulus comprises local electromagnetic radiation.

36. The method of claim 35, wherein the localized electromagnetic radiation is applied using a scanning probe, a scanning electron beam, or a localized light source.

37. The method of claim 31, wherein the activating functional group comprises an amine group.

38. The method of claim 37, further comprising the step of functionalizing the amine to produce a pattern of functional groups selected from the group consisting of amines, amides, ammonium, maleimides, aldehydes, thiols, biotin, alkynes, cycloalkynes, cyclopropenones, olefins, and azides.

39. The method of claim 31, wherein the capture molecule is selected from the group consisting of aptamers, antibodies, antibody fragments, oligonucleotides, peptides, enzymes, nanobodies, and small molecules.

40. The method of claim 31 , wherein the polymer is produced by free radical polymerization.

41. A method of detecting the presence of an analyte of interest, comprising: Providing the device of claim 1; Obtain samples; administering the sample to the device; and Changes in the FET electrical signal are detected, thereby indicating the presence of the target analyte in the sample.

42. The method of claim 41, wherein the target analyte is in a fluid sample.

43. The method of claim 41, wherein the target analyte is in an air sample.

44. The method of claim 41, wherein the target analyte is selected from the group consisting of proteins, nucleic acids, protein fragments, antigens, antibodies, surface receptors, hormones, growth factors, cells, viral particles, bacteria, secreted compounds, heavy metals, toxins, toxic molecules, explosives, pollutants, and metabolites.

45. The method of claim 41, wherein the sample is a sample obtained from a subject.

46. ​​The method of claim 41, wherein the sample is an environmental sample.